ROCÍO
TALAVERÓN AGUILOCHO
Investigadora en el periodo 2016-2022
Instituto de Neurociencias de Castilla y León
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Neurociencias de Castilla y León (8)
2023
-
Antiproliferative effect of boldine on neural progenitor cells and on glioblastoma cells
Frontiers in Neuroscience, Vol. 17
2021
-
Erratum to “Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283” [EBioMedicine 62, December 2020] DOI: https://doi.org/10.1016/j.ebiom.2020.103134 (EBioMedicine (2020) 62, (S2352396420305107), (10.1016/j.ebiom.2020.103134))
EBioMedicine
-
Purinergic receptor blockade with suramin increases survival of postnatal neural progenitor cells in vitro
International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-14
2020
-
Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo
Neuro-Oncology, Vol. 22, Núm. 4, pp. 493-504
-
Connexin43 region 266–283, via src inhibition, reduces neural progenitor cell proliferation promoted by egf and fgf-2 and increases astrocytic differentiation
International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-22
-
Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283
EBioMedicine, Vol. 62
2018
2017
-
A c-Src inhibitor peptide based on connexin43 exerts neuroprotective effects through the inhibition of glial hemichannel activity
Frontiers in Molecular Neuroscience, Vol. 10